Septerna SEPN
NASDAQ SEPN
$38.17 +0.12 (+0.32%)
As of: Oct 2, 2026 · 12:08 PM EDT

Septerna (SEPN) Return on Assets [ROA] (2024 - 2026)

Updated

Septerna's Return on Assets [ROA] was -4.27% in Q2 2026, up 16.34 percentage points from -20.61% a year earlier and up 1.92 percentage points from the prior quarter.

Analysis

Septerna (SEPN) Return on Assets [ROA] (2024 - 2026) Analysis & Trends

For FY2025, Return on Assets [ROA] at Septerna came in at -9.29%, up 15.16 percentage points from FY2024.

  • In earlier years, Return on Assets [ROA] was -24.44% in FY2024.
  • Compared with a year earlier, Return on Assets [ROA] has increased for three straight quarters.
  • Per Business Quant data, SEPN's Return on Assets [ROA] in the three quarters before Q2 2026 was -6.18% (Q1 2026), -8.13% (Q4 2025) and -11.51% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 10.47%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 4.65%
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 2.45%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 28.37%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 9.10%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 9.29%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -6.13%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 2.14%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 16.34%
10 Septerna 1.79 Bn 1.79 Bn - -4.27%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -4.27%
Mar 31, 2026 -6.18%
Dec 31, 2025 -8.13%
Sep 30, 2025 -11.51%
Jun 30, 2025 -20.61%
Mar 31, 2025 -17.81%
Dec 31, 2024 -22.89%
API Access

Septerna Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=SEPN&period=max&api_key=YOUR_API_KEY